Table of Content


Chapter 1. Global Neglected Tropical Diseases Drugs And Vaccines Market Executive Summary
1.1. Global Neglected Tropical Diseases Drugs And Vaccines Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Disease
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Neglected Tropical Diseases Drugs And Vaccines Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Healthcare Systems)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks & Funding
2.3.4.2. Technological Advancements
2.3.4.3. Environmental & Epidemiological Considerations
2.3.4.4. Patient & Community Awareness
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Neglected Tropical Diseases Drugs And Vaccines Market Dynamics
3.1. Market Drivers
3.1.1. Increased Public-Private Partnerships and Funding
3.1.2. Advances in mRNA and Recombinant Vaccine Platforms
3.1.3. Growing Emphasis on Disease Eradication Roadmaps
3.2. Market Challenges
3.2.1. Fragmented Supply Chains and Cold-Chain Limitations
3.2.2. Regulatory Complexities Across Endemic Regions
3.2.3. Limited Commercial Incentives for Low-ROI Indications
3.3. Market Opportunities
3.3.1. Heat-Stable and Oral Formulation Innovations
3.3.2. Integration of Diagnostics with Therapeutic Campaigns
3.3.3. Expansion of Field-Based Clinical Trial Networks
Chapter 4. Global Neglected Tropical Diseases Drugs And Vaccines Market Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Forces
4.1.7. Porter’s 5 Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Neglected Tropical Diseases Drugs And Vaccines Market Size & Forecasts by Product (2022–2032)
5.1. Segment Dashboard
5.2. Market: Drugs vs. Vaccines Revenue Trend Analysis, 2022 & 2032 (USD Billion)
Chapter 6. Global Neglected Tropical Diseases Drugs And Vaccines Market Size & Forecasts by Disease (2022–2032)
6.1. Segment Dashboard
6.2. Market: Lymphatic Filariasis; Echinococcosis; Leishmaniasis; Dracunculiasis; Dengue; Chikungunya Revenue Trend Analysis, 2022 & 2032 (USD Billion)
Chapter 7. Global Neglected Tropical Diseases Drugs And Vaccines Market Size & Forecasts by Region (2022–2032)
7.1. North America Market
7.1.1. U.S. Market
7.1.1.1. Product Breakdown & Forecasts, 2022–2032
7.1.1.2. Disease Breakdown & Forecasts, 2022–2032
7.1.2. Canada Market
7.2. Europe Market
7.2.1. UK
7.2.2. Germany
7.2.3. France
7.2.4. Spain
7.2.5. Italy
7.2.6. Rest of Europe
7.3. Asia Pacific Market
7.3.1. China
7.3.2. India
7.3.3. Japan
7.3.4. Australia
7.3.5. South Korea
7.3.6. Rest of Asia Pacific
7.4. Latin America Market
7.4.1. Brazil
7.4.2. Mexico
7.4.3. Rest of Latin America
7.5. Middle East & Africa Market
7.5.1. Saudi Arabia
7.5.2. South Africa
7.5.3. Rest of Middle East & Africa
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. GlaxoSmithKline plc
8.1.2. Novartis AG
8.1.3. Johnson & Johnson
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. GlaxoSmithKline plc
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Sanofi S.A.
8.3.3. Merck & Co., Inc.
8.3.4. Pfizer Inc.
8.3.5. Bayer AG
8.3.6. Cipla Limited
8.3.7. Eisai Co., Ltd.
8.3.8. Cadila Pharmaceuticals
8.3.9. Serum Institute of India Pvt. Ltd.
8.3.10. Biological E. Limited
8.3.11. Bharat Biotech International Limited
8.3.12. PATH
8.3.13. MedinCell SA
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes



List of Figures

List of Figures
FIG 1. Research methodology
FIG 2. Market estimation techniques
FIG 3. Size estimates & forecast methods
FIG 4. Key trends 2023
FIG 5. Growth prospects 2022–2032
FIG 6. Porter’s 5 Forces model
FIG 7. PESTEL analysis
FIG 8. Value chain analysis
FIG 9. Market by Product, 2022 & 2032 (USD Billion)
FIG 10. Market by Disease, 2022 & 2032 (USD Billion)
FIG 11. Market by Region, 2022 & 2032 (USD Billion)
FIG 12. North America market, 2022 & 2032 (USD Billion)
FIG 13. Europe market, 2022 & 2032 (USD Billion)
FIG 14. Asia Pacific market, 2022 & 2032 (USD Billion)
FIG 15. Latin America market, 2022 & 2032 (USD Billion)
FIG 16. Middle East & Africa market, 2022 & 2032 (USD Billion)
FIG 17. Company market share analysis (2023)
FIG 18. Challenges and opportunities framework
FIG 19. Vaccine versus drug adoption curve
FIG 20. Donor investment landscape overview

List of Tables

List of Tables
TABLE 1. Global NTDs Drugs & Vaccines market, report scope
TABLE 2. Market estimates & forecasts by Region 2022–2032 (USD Billion)
TABLE 3. Estimates & forecasts by Product 2022–2032 (USD Billion)
TABLE 4. Estimates & forecasts by Disease 2022–2032 (USD Billion)
TABLE 5. North America market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 6. U.S. market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 7. Canada market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 8. Europe market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 9. UK market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 10. Germany market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 11. Asia Pacific market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 12. India market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 13. Latin America market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 14. Brazil market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 15. Middle East & Africa market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 16. Saudi Arabia market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 17. South Africa market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 18. Global competitive landscape analysis, 2023
TABLE 19. Historical vs. forecast comparison, 2022–2032 (USD Billion)
TABLE 20. Key donor funding trends, 2022–2032